Pixcelldata, eX-Path announce major new deal in advance of ECP 2014

NewsGuard 100/100 Score

Pixcelldata, the innovative Irish developer of digital pathology management and collaboration software has announced a major new deal with Dutch based eX-Path, global providers of tele-pathology services, founded by renowned pathology expert, Dr. Marius Nap.

The announcement was made in advance of the 26th European Congress of Pathology which is taking placing between August 30th and September 3rd in the ExCeL Arena, London where Pixcelldata will demonstrate its innovative solution.

Founded in 2013, eX-Path specialises in processing and diagnosis of patient tissue samples. A key area for the company is the provision of an Immunohistochemistry (IHC) service support to pathologists located across the globe.

Once the samples have been prepared and analysed, eX-Path provides access to the image-rich pathology data between various locations for the purpose of diagnostics, research and education.

Pixcelldata's Collibio software, which is an advanced web application for storing, managing, reviewing, and sharing digital pathology images and associated case data, will be used as the collaboration platform for samples.

Marius Nap, Head of Pathology and Co-Founder of eX-Path said, "IHC is a powerful tool for pathologists because it gives them the answers to questions that are impossible to solve using other techniques.

However, it can be quite a difficult process, particularly for those operating in the developing world where standardised laboratories and lab equipment are not available, or where there is no easy access to costly antibodies.

Collibio will allow us to provide whole slide images to pathologists located anywhere in the world thus improving our efficiency and interoperability, not to mention the cost saving benefits that it also provides."

Alan Hanley, CEO of Pixcelldata said, "We are delighted to work with eX-Path and Dr. Marius Nap. Dr. Nap is a highly-respected pioneer in the field of digital pathology and this partnership will see both of our companies working in tandem for the benefit of our mutual clients, to ensure that they gain the vast improvements available through modern digital imaging solutions."

Source:

Pixcelldata

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advancing computational pathology with UNI and CONCH foundation models